Author

Emir Salas‐Sarduy

Consejo Nacional de Investigaciones Científicas y TécnicasORCID 0000-0002-9709-7552Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

Fernán AgüeroiD· 2 shared Mercedes Didier GarnhamiD· 2 shared Fátima Agüero· 1 shared Juan Carlos Ramírez· 1 shared Lionel Urán LandaburuiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

5 top collaborators · 8 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Fernán AgüeroORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Prioritization of chemical scaffolds using the TDR Targets database: an integrative workflow for Trypanosoma cruzi drug discovery

Lionel Urán Landaburu, Mercedes Didier Garnham, Emir Salas‐Sarduy, Fernán Agüero

This paper prioritizes chemical scaffolds for Trypanosoma cruzi drug discovery using the TDR Targets database, identifying 378 high-priority compounds and validating 7 with selective trypanocidal activity.

PLoS neglected tropical diseases · Aug 24, 2026Peer-reviewedMicrobiology

Identification of antifungal agents AR-12 and Fosmanogepix as anti-Trypanosoma cruzi drugs through an enhanced fluorogenic β-galactosidase phenotypic screening assay

Mercedes Didier Garnham, Fátima Agüero, Juan Carlos Ramírez, Fernán Agüero, Emir Salas‐Sarduy

This paper develops a fluorogenic β-galactosidase assay to screen antifungal compounds against Trypanosoma cruzi, identifying AR-12 and Fosmanogepix as potential drugs.

ACS Infectious Diseases · Jan 2, 2026Peer-reviewedMicrobiology